Guo, P. Wang, F. Hu, D. Zhu, F. Yang, M. Wang; Huashan Hosp., Shanghai, China. Echaniz-Aviles Ardanuy Adam

145 TUESDAY SCIENTIFIC SESSIONS Final Program C2-1354 Rapid Decrease in 7-Valent Conjugate Vaccine Coverage for Invasive Pneumococcal Diseases IPD in Pediatric Patients in Japan

K. Ubukata

1 , N. Chiba 1 , M. Morozumi 1 , H. Sakata 2 , S. Iwata 3 ; 1 Kitasato Inst. for Life Sci.,Kitasato Univ., Tokyo, Japan, 2 Asahikawa-Kosei Gen. Hosp., Asahikawa, Japan, 3 Keio Univ. Sch. of Med., Tokyo, Japan. C2-1355 Quinolone-Nonsusceptible Streptococcus pneumoniae Clinical Isolates in China

Q. Guo, P. Wang, F. Hu, D. Zhu, F. Yang, M. Wang; Huashan Hosp., Shanghai, China.

C2-1356 Laboratory Surveillance of Pneumococcal serotypes and Anti- microbial Susceptibility Before and After Pcv7 in Mexico Sireva 2000-2011

G. Echaniz-Aviles

1 , M. Carnalla-Barajas 1 , A. Soto-Noguerón 1 , M. Velazquez-Meza 1 , M. Sanchez-Alemán 1 , M. Hernández-Salgado 1 , F. Solórzano-Sánchez 2 , SIREVA-Mexico Network; 1 Inst. Nacional de Salud Publ., Cuernavaca, Morelos, Mexico, 2 Inst. Mexicano del Seguro Social, Mexico City, Mexico. C2-1357 S19A and Coverage of Pneumococcal Conjugate Vaccines in Mexico R. M. Hinojosa-Robles, M. J. De la Cruz-Váldez, P. A. Hernández- Rodríguez, C. Martínez-Longoria, L. Vera-Cabrera; Hosp. Univ., U.A.N.L., Monterrey, Mexico. C2-1358 Characteristics of Invasive Pneumococci Collected from Adults Prior 13-Valent Conjugated Vaccine pcv13 Introduction in Spain

C. Ardanuy

1 , J. Marimón 2 , E. Cercenado 3 , N. Larrosa 4 , D. Fontanals 5 , M. Quesada 6 , A. Fenoll 7 , E. Pérez-Trallero 2 , J. Liñares 1 ; 1 Hosp Univ. Bellvitge- IDIBELL, L’Hosp. de Llobregat, Spain, 2 Hosp. Univ. Donostia, Donostia, Spain, 3 Hosp. Univ. Gregorio Marañón, Madrid, Spain, 4 Hosp. Univ. Vall d’Hebron, Barcelona, Spain, 5 Hosp. Parc Taulí, Sabadell, Spain, 6 Hosp. Germans Trias i Pujol, Badalona, Spain, 7 Ctr. Natl. Microbiologia-ISCIII, Majadahonda, Spain. C2-1359 Changes in Epidemiology of Invasive Strains of Streptococcus pneumoniae Spn in France Following Introduction of 13-Valent Conjugate Vaccine PCV13 7 years after PCV7 C. Janoir 1 , Reseau des Observatoires Regionaux du Pneumocoque, L. Gut- mann 1 , A. Lepoutre 2 , E. Varon 1 ; 1 AP-HP, Hosp. Europeen G-Pompidou - CNRP, Paris, France, 2 InVS, St Maurice, France. C2-1360 Multidrug-Resistance in the Most Prevalent Invasive Strep- tococcus pneumoniae SPN Serotypes STs Post PCV-13 Introduc- tion in Canada

H. Adam

1,2,3 , M. Gilmour 4,2 , M. Baxter 2,3 , I. Martin 4 , L. Scharikow 2 , K. Nichol 1,3 , W. Demczuk 4 , J. Embree 2 , D. Hoban 1,2,3 , G. G. Zhanel 2,3 ; 1 Diagnostic Services of Manitoba, Winnipeg, Canada, 2 Univ. of Manitoba, Winnipeg, Canada, 3 Canadian Antimicrobial Resistance Alliance CARA, Winnipeg, Canada, 4 Natl. Microbiol. Lab., Winnipeg, Canada. C2-1361 Epidemiology of Serotype 19A Streptococcus pneumoniae in Adults Over the Past Decade

B. E. Gonzalez